drugset / Trial / NCT01334697
Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blind
Summary
The general aim of the study is to determinate safety, tolerability and early pharmacokinetics of cardiotrophin.1 in healthy volunteers.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cardiotrophin-1 | Protein / enzyme biologic | — | Intravenous |
Indications
No indication recorded.